Atea Pharmaceuticals: The U.S. FDA Granted Fast Track Designation to Bemnifosbuvir Oral Antiviral for COVID-19

Atea Pharmaceuticals Receives Fast Track Designation for Bemnifosbuvir Atea Pharmaceuticals ( AVIR ) announced that the U.S. FDA has granted Fast Track designation to its product bemnifosbuvir for the...